Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers
Clinical trial NCT06607770 · RECRUITING
Trial details
- NCT number
- NCT06607770
- Sponsor
- Zhou Chengzhi
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2026-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.